ArticleInternational journal of nanomedicine2026
Cyclodextrin-Based Nanogels with Chemistry-Tunable Intracellular Stability and Distribution.
Article in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cyclodextrin-based nanogels (CD-nGels) uniquely enable encapsulation of hydrophobic pharmaceuticals within hydrophilic networks through host-guest interactions, thereby improving drug solubility, stability, and therapeutic efficacy. Methods: Here, we report the surfactant-free synthesis of Nile Blue-labeled fluorescent CD-nGels with tunable hydrolytic properties by integrating amide or ester linkages in both β-cyclodextrin (βCD) moieties and crosslinking sites. Three formulations were prepared with progressively increasing hydrolytic sensitivity: NG1 (fully amide-linked), NG2 (ester-functionalized βCD with amide crosslinking), and NG3 (ester linkages in both βCD and crosslinker domains). Results: The resulting CD-nGels were monodisperse with hydrodynamic diameters ranging from 247 to 431 nm. Hydrolysis study in mildly acidic conditions (pH 5.1) and in intracellular-mimicking MCF-7 lysate demonstrated that the structural stability is predominantly dictated by chemical compositions. Coumarin-6 (C6), a hydrophobic fluorescent model drug, was efficiently encapsulated via host-guest interactions to visualize the intracellular redistribution after cellular uptake. The confocal microscopy revealed that the three CD-nGel formulations exhibited progressively enhanced intracellular degradability, leading to distinct intracellular fluorescence distributions: while the fully amide-linked NG1 maintained a compact intracellular fluorescence pattern, the ester-containing NG2 and NG3 exhibited progressively diffuse cytoplasmic signals consistent with reduced structural stability. Discussion: Overall, this modular platform enables chemical tuning of intracellular stability and distribution of CD-nGels, providing a design basis for the future development of CD-based nGels for controlled intracellular drug delivery applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.